阻害性Gタンパク質過剰発現は,持続的な心房動で生理学的に関連する心拍数制御を提供します
Alexander Bauer1, Amy D McDonald, Khurram Nasir
1Johns Hopkins University, Baltimore, MD 21205, USA.
Circulation
|October 27, 2004
まとめ
動脈節における構成的に活性なGalpha(i2) (cGi) を用いた遺伝子治療は,持続的な心房細動と心不全の豚モデルにおいて,心拍数を効果的に制御した.
科学分野:
- 心血管研究 循環器科の研究
- 遺伝子療法の遺伝子治療法
- 分子心臓病学 分子心臓病学
背景:
- 心律失調症は,新しい治療戦略を必要とします.
- 以前の研究では,急性心房動における心房節遺伝子移転後の心拍数低下が示されました.
- この研究は,知見を持続的な心房細動および重度の心不全モデルに拡張しています.
研究 の 目的:
- 持続的な心房動および心不全の管理のための心房動節の遺伝子転送の有効性を調査する.
- 心拍数と心臓機能に対する特定のGalpha (((i2) 遺伝子変異の影響を評価する.
主な方法:
- 誘発性絶え間ない心房細動と心拍動脈に起因する心筋症候群の家畜豚は,心房節性遺伝子移植を受けた.
- ベータ-ガラクトシダゼをコードするアデノウイルス (対照群),野生型のGalpha (i2) (wtGi),または構成的に活性なGalpha (i2) (cGi) を使用した.
- 心拍数,エジェクション分数,心臓機能が評価され,細胞死に対するTUNEL染色が行われました.
主要な成果:
- 構成的に活性なGalpha (i2) (cGi) の過剰発現は,心拍数に持続的な15%~25%の低下をもたらしました.
- 野生型のGalpha (i2) (wtGi) は,主に鎮静状態で効果を示した.
- cGi遺伝子移植を受けた動物は,正常に近いエエジェクション分数を呈し,心臓機能の改善を示し,対照群は心臓筋病の悪化を示した.
結論:
- 豚の心房動脈節におけるcGiの過剰発現は,持続的な心房動において生理学的に重要な心拍数制御を提供します.
- これらの発見は,一般的な心律失調症の潜在的な治療法として,遺伝子療法の進歩を支持しています.
- 心房中枢節を標的とした遺伝子治療は,複雑な心疾患の管理に有望であることを示しています.
関連する概念動画
Factors Influencing Heart Rate
5.6K
The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
5.6K
G-Protein Gated Ion Channels
5.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.5K
GPCRs Regulate Adenylyl Cylase Activity
6.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Antihypertensive Drugs: Action of β1 Blockers
2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Pathophysiology of Cardiac Performance
2.2K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.2K
Regulation of Heart Rates
6.0K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
6.0K


